Arvinas (ARVN) Short-term Investments (2017 - 2026)

Arvinas' (ARVN) quarterly Short-term Investments came in at $527.6 million in Q1 2026, down 39.59% year-on-year from $873.3 million in Q1 2025, and down 2.75% quarter-over-quarter from $542.5 million in Q4 2025.

Arvinas (ARVN) Short-term Investments (2017 - 2026) Analysis & Trends

Arvinas' Short-term Investments history runs 10 years deep, the most recent figure standing at $527.6 million for Q1 2026.

  • On a quarterly basis, Short-term Investments fell 39.59% year-over-year to $527.6 million in Q1 2026; TTM through Mar 2026 was $527.6 million, a 39.59% decrease from a year earlier, with the FY2025 full-year figure at $542.5 million, down 42.22% from the prior year.
  • Short-term Investments slipped to $527.6 million in Q1 2026 per ARVN's latest filing, from $542.5 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.1 billion in Q1 2024 and bottomed at $4.5 million in Q1 2022.
  • The 5-year median for Short-term Investments is $5.5 million (2022), against an average of $340.2 million.
  • Across the five-year window, Short-term Investments slumped 99.57% in 2022 and surged 19560.0% in 2024, its largest moves.
  • Year by year, Short-term Investments stood at $5.5 million in 2022, then changed by 0.0% to $5.5 million in 2023, then soared by 16970.91% to $938.9 million in 2024, then plunged by 42.22% to $542.5 million in 2025, then retreated by 2.75% to $527.6 million in 2026.
  • Per Business Quant, the three latest ARVN Short-term Investments figures stand at $527.6 million (Q1 2026), $542.5 million (Q4 2025), and $686.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Arvinas 512.64 Mn -102.26 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 527.60 Mn
Dec 31, 2025 542.50 Mn
Sep 30, 2025 686.10 Mn
Jun 30, 2025 746.30 Mn
Mar 31, 2025 873.30 Mn
Dec 31, 2024 938.90 Mn
Jun 30, 2024 5.50 Mn
Mar 31, 2024 1.08 Bn
Dec 31, 2023 5.50 Mn
Sep 30, 2023 5.50 Mn
Jun 30, 2023 5.50 Mn
Mar 31, 2023 5.50 Mn
Dec 31, 2022 5.50 Mn
Sep 30, 2022 5.50 Mn
Jun 30, 2022 4.50 Mn
Mar 31, 2022 4.50 Mn
Dec 31, 2021 4.50 Mn
Sep 30, 2021 1.29 Bn
Jun 30, 2021 4.50 Mn
Mar 31, 2021 305.20 Mn